Close
Diversified Energy Closes Market Leading Securitized Financing Jun 3, 2024 07:00AM

Solidifies Standing as the First, Largest and Consistent Performing Issuer of PDP Oil & Gas Securitizations

BIRMINGHAM, AL / ACCESSWIRE / June 3, 2024 / Diversified Energy Company PLC (LSE: DEC)(NYSE: DEC) ("Diversified" or the "Company") is pleased to announce that on May 30, 2024, the Company closed on an asset backed securitization ("ABS") refinancing, creating the ABSVIII note (the "Transaction"). Diversified will use the proceeds from the Transaction to repay the... (continue reading...)


NXT Announces Fully Subscribed US$2.0 Million Convertible Debenture Jun 3, 2024 07:00AM

CALGARY, AB / ACCESSWIRE / June 3, 2024 / NXT Energy Solutions Inc. ("NXT" or the "Company") (TSX:SFD)(OTCQB: NSFDF) is pleased to announce it has issued convertible debentures (the "Debentures") to MCAPM LP for the principal amount of US$2,000,000, being approximately CDN$2,742,800, pursuant to the terms of a subscription agreement with NXT. The Toronto Stock Exchange (the "TSX") has provided conditional approval of the private placement. The Debentures bear interest... (continue reading...)


Prelude Therapeutics to Participate in Upcoming Healthcare Conferences Jun 3, 2024 07:01AM

WILMINGTON, Del., June 03, 2024 (GLOBE NEWSWIRE) -- Prelude Therapeutics Incorporated (Nasdaq: PRLD), a clinical-stage precision oncology company, announced today that the Company will participate in two upcoming healthcare conferences in June.

Jefferies Global Healthcare Conference 2024:On Thursday, June 6th, at 1:30 p.m. ET, Kris Vaddi, Ph.D., Chief Executive Officer of Prelude will participate in a fireside chat. A live webcast of the fireside chat can be accessed... (continue reading...)


Stallion Uranium Closes Sale of Non-Core Uranium Projects in Eastern Athabasca Basin Jun 3, 2024 07:00AM

VANCOUVER, British Columbia, June 03, 2024 (GLOBE NEWSWIRE) -- Stallion Uranium Corp. (the "Company" or "Stallion") (TSX-V: STUD; OTCQB: STLNF; FSE: HM40) is pleased to announce that, further to its news release dated February 13, 2024, the Company has closed the purchase and sale agreement dated February 12, 2024 (the “Agreement”), under which the Company has sold Glorious Creation Limited (“Glorious”) 100% interest in its three Eastern Basin Projects,... (continue reading...)


Fortrea to Present at the Jefferies Global Healthcare Conference Jun 3, 2024 07:00AM

DURHAM, N.C., June 03, 2024 (GLOBE NEWSWIRE) -- Fortrea (Nasdaq: FTRE), a leading global contract research organization (CRO), today announced that Chairman and Chief Executive Officer, Tom Pike and Chief Financial Officer, Jill McConnell will present at the Jefferies Global Healthcare Conference on Wednesday, June 5, 2024 at 11:00 am ET.

The live webcast will be available to investors and other interested parties by accessing the Fortrea Investor Relations... (continue reading...)


More Press Releases

View Older Stories

Jun 3, 2024 07:00AM RedHill Announces a New Patent Covering Opaganib in Combination with Immune Checkpoint Inhibitors, Valid Through 2040
Jun 3, 2024 07:00AM Marriott International Announces Three Conversions to Bring Iconic Luxury Properties in the United States into the Marriott Bonvoy Portfolio Later This Summer
Jun 3, 2024 07:00AM PawFury's Presale Raises Over $3 Million, Set To Surpass Pepe and SHIB
Jun 3, 2024 07:00AM Coalesce Capital Announces Key Hires as Firm Continues to Expand Leadership Team
Jun 3, 2024 07:00AM Dominion Energy Announces Closing of Sale of Western Natural Gas Distribution Assets Questar Gas, Wexpro
Jun 3, 2024 07:00AM FibroGen to Present at Goldman Sachs 45th Annual Global Healthcare Conference
Jun 3, 2024 07:00AM PEAK ROCK CAPITAL AFFILIATE COMPLETES PREVIOUSLY ANNOUNCED ACQUISITION OF HUFRIEDYGROUP
Jun 3, 2024 07:00AM Calidi Biotherapeutics Presents CLD-101 Phase 1 Trial Update and Preclinical Data Highlighting RTNova and CLD-201 at 2024 ASCO Annual Meeting
Jun 3, 2024 07:00AM Axsome Therapeutics Supports Alzheimer’s & Brain Awareness Month
Jun 3, 2024 07:00AM At ASCO 2024, Treos Bio Reports Key Survival Results for Chemo-Free Regimen of PolyPEPI1018 Peptide Immunotherapy and Roche’s PD-L1 Inhibitor in Late-Stage Colorectal Cancer
Jun 3, 2024 07:00AM ATHA Energy Commences 2024 Angilak Diamond Drilling Exploration Program
Jun 3, 2024 07:00AM Recurrent Energy Announces Initial Closing of Investment from BlackRock
Jun 3, 2024 07:00AM Xeris Presents New Post Hoc Analysis on Effects of Levoketoconazole (Recorlev®) in Cushing’s Syndrome Patients at ENDO 2024
Jun 3, 2024 07:00AM Osisko Development to Complete Second Deferred Payment Installment in Connection With the Tintic Acquisition
Jun 3, 2024 07:00AM Labcorp Announces New Strategic Service Offerings within Precision Oncology Portfolio
Jun 3, 2024 07:00AM Grey Wolf Therapeutics Presents First Clinical Data for GRWD5769, a First-in-Class ERAP1 Inhibitor, at the 2024 American Society for Clinical Oncology (ASCO) Annual Meeting
Jun 3, 2024 07:00AM Pulsenmore Appoints Len Farris as Chief Commercial Officer to Lead Global Expansion of Breakthrough Home Ultrasound Technology
Jun 3, 2024 07:00AM Pershing Square Holdings, Ltd. Notes the Sale by Pershing Square Capital Management, L.P. of a 10% Common Equity Interest to Strategic Investors
Jun 3, 2024 07:00AM Skye Bioscience to Present at Jefferies Global Healthcare Conference
Jun 3, 2024 07:00AM StateServ Rebrands to Dragonfly Health
Jun 3, 2024 07:00AM EagleRider Motorcycle Rental and Tours Announces New CEO Sebastian Schoepe
Jun 3, 2024 07:00AM Enbridge Completes Acquisition of Questar Gas Company
Jun 3, 2024 07:00AM Quince Therapeutics Receives U.S. FDA Fast Track Designation for EryDex System
Jun 3, 2024 07:00AM Flow Beverage Corp. to Release Second Quarter 2024 Financial Results
Jun 3, 2024 07:00AM Consor Holdings Announces Growth Investment from New Mountain Capital
Jun 3, 2024 07:00AM Graphite One Announces Repricing of Stock Options
Jun 3, 2024 07:00AM International Energy Forum Report Details EV Copper Hurdles
Jun 3, 2024 07:00AM Dunes Point Capital, LP Announces Roofing Services Solutions' Acquisition of West Orange Roofing, LLC
Jun 3, 2024 07:00AM Beyond Cancer Presents First-in-Class Clinical Data Showing an Immunogenic Response in Subjects with r/r Unresectable Solid Tumors Treated with Ultra-High Concentration Nitric Oxide (UNO)
Jun 3, 2024 07:00AM Lithium Drilling Program Commences at East Vallée
Jun 3, 2024 07:00AM Bruker Launches Transformative neofleX™ MALDI-TOF System for Spatial Biology Mass Spec Imaging (MSI) Applications
Jun 3, 2024 07:00AM Gryphon Investors-Backed Thermal Technology Distribution Solutions Acquires Southwest Heater and Controls
Jun 3, 2024 07:00AM Catona Climate to Offer High-Quality Carbon Credits through Integration with GreenLight Solution by Deloitte
Jun 3, 2024 07:00AM Bausch + Lomb Launches Blink™ NutriTears® Clinically Proven Nutritional Supplement for Dry Eyes in the United States
Jun 3, 2024 07:00AM Spruce Biosciences Presented Phase 2 POWER Study Results of Tildacerfont for the Treatment of Polycystic Ovary Syndrome at ENDO 2024
Jun 3, 2024 07:00AM Andreas Nix is the new COO of the ZKW Group
Jun 3, 2024 07:00AM TriSalus Life Sciences Highlights Clinical Data from Phase 1b PERIO-02 Trial, Studying Delivery of Nelitolimod via Pressure-Enabled Drug Delivery in Patients with Hepatocellular Carcinoma or Intrahepa
Jun 3, 2024 07:00AM Ventra Health Appoints Erika Flowers as Chief People Officer
Jun 3, 2024 07:00AM Alzheimer's Association Encourages Americans to Take Charge of Their Brain Health
Jun 3, 2024 07:00AM IDRx Reports Updated Preliminary Phase 1 Data from Ongoing Phase 1/1b StrateGIST 1 Trial Supporting Best-in-Class Potential for IDRX-42 in Patients with GIST
Jun 3, 2024 07:00AM redT Homes Honored as Best Individual Electric Only Builder Overall in 2023 Xcel ESNH Program
Jun 3, 2024 07:00AM Rockwell Automation to Advance Intelligent Automation, Mobile Robotics in Manufacturing Logistics in Collaboration with NVIDIA
Jun 3, 2024 07:00AM Aruna BIO Announces Appointment of Lynn Swann to its Board of Directors
Jun 3, 2024 07:00AM Yellow Wood Partners Portfolio Company Suave Brands Company Completes ChapStick Acquisition
Jun 3, 2024 07:00AM ModernFi Announces Integration with Q2's Digital Banking Platform
Jun 3, 2024 07:00AM Pershing Square Capital Management, L.P. Announces Sale of 10% Common Equity Interest for $1.05 Billion to Strategic Investors
Jun 3, 2024 07:00AM BPGbio Appoints Biopharma Industry Leader Scott Minick to Board of Directors
Jun 3, 2024 07:00AM Alkermes Presents Data From Phase 1b Study of ALKS 2680 Demonstrating Improved Wakefulness in Patients With Narcolepsy Type 1 at SLEEP 2024
Jun 3, 2024 07:00AM Turing Medical Launches New Brain Mapping and Targeting Solution at ASSFN Biannual Meeting
Jun 3, 2024 07:00AM Dovenmuehle announces strategic business development promotions to support demand for its mortgage subservicing offerings
View Older Stories